US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist

9.310
+0.230+2.53%

Close Nov 21 16:00 ET

9.100
-0.210-2.26%

Post 17:16 ET

197.27MMarket Cap-1708P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jun 30, 2024

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

54.01%-14.78M

-107.51%-28.6M

29.89%-24.99M

-21.67%-103.15M

-39.06%-21.6M

-8.53%-32.13M

47.74%-13.78M

-168.56%-35.64M

-21.12%-84.78M

26.10%-15.53M

Net income from continuing operations

42.00%-22.66M

17.26%-31.16M

-15.25%-33.41M

-9.91%-133.82M

-6.68%-28.11M

-23.23%-39.07M

-12.10%-37.66M

3.75%-28.99M

-54.13%-121.76M

-7.11%-26.35M

Operating gains losses

----

--150K

--143K

--0

----

Depreciation and amortization

-8.76%594K

15.00%621K

25.64%642K

-20.25%2.37M

2.14%669K

-9.08%651K

-34.31%540K

-34.49%511K

-10.83%2.97M

-18.73%655K

Deferred tax

----

--0

----

--0

----

Other non cash items

-129.91%-588K

---304K

--786K

-464.37%-5.24M

-8,534.94%-7.17M

4,568.18%1.97M

----

77.33%-929K

87.63%-83K

Change In working capital

318.93%2.7M

-119.67%-3.35M

90.10%-1.38M

18.19%8.02M

84.98%6.21M

80.67%-1.23M

13,186.92%17.01M

-240.64%-13.97M

149.60%6.79M

217.55%3.36M

-Change in receivables

-147.95%-844K

-97.46%120K

87.17%-289K

-20.15%9.42M

726.18%5.19M

336.88%1.76M

-47.19%4.72M

-150.81%-2.25M

148.54%11.8M

90.40%-829K

-Change in prepaid assets

-67.30%-4.33M

-33.19%2.31M

100.40%18K

-75.50%182K

299.90%3.81M

-201.93%-2.59M

234.60%3.46M

-267.82%-4.5M

239.40%743K

7.12%-1.91M

-Change in payables and accrued expense

536.10%2.53M

-181.80%-5.89M

78.56%-1.56M

39.31%-3.71M

-153.38%-3.04M

92.31%-579K

205.45%7.2M

-386.47%-7.29M

-150.40%-6.11M

-31.01%5.7M

-Change in other current assets

9.95%1.43M

59.22%1.68M

73.86%1.45M

7.65%4.49M

53.23%1.3M

141.34%1.3M

-21.59%1.06M

-41.92%834K

-23.00%4.17M

-39.17%851K

-Change in other current liabilities

426.14%3.22M

-368.12%-1.54M

-36.99%-1.04M

38.11%-2.36M

-159.39%-1.19M

15.78%-987K

156.44%574K

34.91%-757K

40.46%-3.81M

74.89%-458K

-Change in other working capital

----

860.00%38K

----

---5K

----

Cash from discontinued investing activities

Operating cash flow

54.01%-14.78M

-107.51%-28.6M

29.89%-24.99M

-21.67%-103.15M

-39.06%-21.6M

-8.53%-32.13M

47.74%-13.78M

-168.56%-35.64M

-21.12%-84.78M

26.10%-15.53M

Investing cash flow

Cash flow from continuing investing activities

95.65%-6.35M

25.36%58.62M

-139.07%-13.12M

-197.60%-53.58M

-58.07%11.84M

-998.57%-145.75M

233.40%46.77M

-26.22%33.57M

48.41%54.9M

-61.16%28.23M

Net PPE purchase and sale

-204.14%-6.54M

30.00%-1.67M

75.06%-787K

-326.26%-9.06M

4.80%-1.37M

-756.97%-2.15M

-3,120.27%-2.38M

-769.42%-3.16M

-183.33%-2.13M

-4,254.55%-1.44M

Net investment purchase and sale

100.14%197K

22.67%60.29M

-133.57%-12.33M

-178.08%-44.52M

-55.49%13.2M

-971.82%-143.6M

240.50%49.15M

-19.93%36.73M

51.09%57.02M

-59.20%29.67M

Cash from discontinued investing activities

Investing cash flow

95.65%-6.35M

25.36%58.62M

-139.07%-13.12M

-197.60%-53.58M

-58.07%11.84M

-998.57%-145.75M

233.40%46.77M

-26.22%33.57M

48.41%54.9M

-61.16%28.23M

Financing cash flow

Cash flow from continuing financing activities

-103.33%-6.65M

-216.43%-6.41M

-2,541.86%-7.35M

889.00%198.13M

-100.78%-23K

4,751.33%199.88M

-160.49%-2.03M

-96.88%301K

550.42%20.03M

210.71%2.93M

Net issuance payments of debt

----

---7.17M

----

--0

----

Proceeds from stock option exercised by employees

-86.00%28K

-94.22%51K

--0

-89.62%2.21M

--0

-95.15%200K

-76.80%882K

-89.18%1.13M

488.32%21.26M

210.82%2.93M

Net other financing activities

-93.22%13.54M

-368.61%-13.63M

77.82%-183K

16,041.25%195.92M

-2,200.00%-23K

--199.68M

-545.01%-2.91M

-6.18%-825K

-130.15%-1.23M

---1K

Cash from discontinued financing activities

Financing cash flow

-103.33%-6.65M

-216.43%-6.41M

-2,541.86%-7.35M

889.00%198.13M

-100.78%-23K

4,751.33%199.88M

-160.49%-2.03M

-96.88%301K

550.42%20.03M

210.71%2.93M

Net cash flow

Beginning cash position

-12.49%67.51M

-4.96%43.9M

86.31%89.36M

-17.04%47.96M

206.62%99.15M

85.46%77.15M

-53.66%46.19M

-17.04%47.96M

-34.11%57.81M

520.75%32.34M

Current changes in cash

-226.22%-27.77M

-23.73%23.61M

-2,466.63%-45.46M

520.16%41.39M

-162.64%-9.79M

337.52%22M

153.30%30.96M

-104.23%-1.77M

67.08%-9.85M

-70.29%15.63M

End cash Position

-59.91%39.74M

-12.49%67.51M

-4.96%43.9M

86.31%89.36M

206.62%99.15M

85.46%77.15M

-53.66%46.19M

-17.04%47.96M

Free cash flow

37.81%-21.32M

-87.24%-30.27M

33.56%-25.78M

-29.12%-112.21M

-35.35%-22.97M

-14.83%-34.28M

38.88%-16.17M

-184.56%-38.8M

-22.84%-86.91M

19.39%-16.97M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Jun 30, 2024	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	54.01%-14.78M	-107.51%-28.6M	29.89%-24.99M	-21.67%-103.15M	-39.06%-21.6M	-8.53%-32.13M	47.74%-13.78M	-168.56%-35.64M	-21.12%-84.78M	26.10%-15.53M
Net income from continuing operations	42.00%-22.66M	17.26%-31.16M	-15.25%-33.41M	-9.91%-133.82M	-6.68%-28.11M	-23.23%-39.07M	-12.10%-37.66M	3.75%-28.99M	-54.13%-121.76M	-7.11%-26.35M
Operating gains losses	----	----	----	--150K	--143K	--0	----	----	----	----
Depreciation and amortization	-8.76%594K	15.00%621K	25.64%642K	-20.25%2.37M	2.14%669K	-9.08%651K	-34.31%540K	-34.49%511K	-10.83%2.97M	-18.73%655K
Deferred tax	----	----	----	--0	----	----	----	----	--0	----
Other non cash items	-129.91%-588K	---304K	--786K	-464.37%-5.24M	-8,534.94%-7.17M	4,568.18%1.97M	----	----	77.33%-929K	87.63%-83K
Change In working capital	318.93%2.7M	-119.67%-3.35M	90.10%-1.38M	18.19%8.02M	84.98%6.21M	80.67%-1.23M	13,186.92%17.01M	-240.64%-13.97M	149.60%6.79M	217.55%3.36M
-Change in receivables	-147.95%-844K	-97.46%120K	87.17%-289K	-20.15%9.42M	726.18%5.19M	336.88%1.76M	-47.19%4.72M	-150.81%-2.25M	148.54%11.8M	90.40%-829K
-Change in prepaid assets	-67.30%-4.33M	-33.19%2.31M	100.40%18K	-75.50%182K	299.90%3.81M	-201.93%-2.59M	234.60%3.46M	-267.82%-4.5M	239.40%743K	7.12%-1.91M
-Change in payables and accrued expense	536.10%2.53M	-181.80%-5.89M	78.56%-1.56M	39.31%-3.71M	-153.38%-3.04M	92.31%-579K	205.45%7.2M	-386.47%-7.29M	-150.40%-6.11M	-31.01%5.7M
-Change in other current assets	9.95%1.43M	59.22%1.68M	73.86%1.45M	7.65%4.49M	53.23%1.3M	141.34%1.3M	-21.59%1.06M	-41.92%834K	-23.00%4.17M	-39.17%851K
-Change in other current liabilities	426.14%3.22M	-368.12%-1.54M	-36.99%-1.04M	38.11%-2.36M	-159.39%-1.19M	15.78%-987K	156.44%574K	34.91%-757K	40.46%-3.81M	74.89%-458K
-Change in other working capital	----	----	860.00%38K	----	----	----	----	---5K	----	----
Cash from discontinued investing activities
Operating cash flow	54.01%-14.78M	-107.51%-28.6M	29.89%-24.99M	-21.67%-103.15M	-39.06%-21.6M	-8.53%-32.13M	47.74%-13.78M	-168.56%-35.64M	-21.12%-84.78M	26.10%-15.53M
Investing cash flow
Cash flow from continuing investing activities	95.65%-6.35M	25.36%58.62M	-139.07%-13.12M	-197.60%-53.58M	-58.07%11.84M	-998.57%-145.75M	233.40%46.77M	-26.22%33.57M	48.41%54.9M	-61.16%28.23M
Net PPE purchase and sale	-204.14%-6.54M	30.00%-1.67M	75.06%-787K	-326.26%-9.06M	4.80%-1.37M	-756.97%-2.15M	-3,120.27%-2.38M	-769.42%-3.16M	-183.33%-2.13M	-4,254.55%-1.44M
Net investment purchase and sale	100.14%197K	22.67%60.29M	-133.57%-12.33M	-178.08%-44.52M	-55.49%13.2M	-971.82%-143.6M	240.50%49.15M	-19.93%36.73M	51.09%57.02M	-59.20%29.67M
Cash from discontinued investing activities
Investing cash flow	95.65%-6.35M	25.36%58.62M	-139.07%-13.12M	-197.60%-53.58M	-58.07%11.84M	-998.57%-145.75M	233.40%46.77M	-26.22%33.57M	48.41%54.9M	-61.16%28.23M
Financing cash flow
Cash flow from continuing financing activities	-103.33%-6.65M	-216.43%-6.41M	-2,541.86%-7.35M	889.00%198.13M	-100.78%-23K	4,751.33%199.88M	-160.49%-2.03M	-96.88%301K	550.42%20.03M	210.71%2.93M
Net issuance payments of debt	----	----	---7.17M	----	----	----	----	--0	----	----
Proceeds from stock option exercised by employees	-86.00%28K	-94.22%51K	--0	-89.62%2.21M	--0	-95.15%200K	-76.80%882K	-89.18%1.13M	488.32%21.26M	210.82%2.93M
Net other financing activities	-93.22%13.54M	-368.61%-13.63M	77.82%-183K	16,041.25%195.92M	-2,200.00%-23K	--199.68M	-545.01%-2.91M	-6.18%-825K	-130.15%-1.23M	---1K
Cash from discontinued financing activities
Financing cash flow	-103.33%-6.65M	-216.43%-6.41M	-2,541.86%-7.35M	889.00%198.13M	-100.78%-23K	4,751.33%199.88M	-160.49%-2.03M	-96.88%301K	550.42%20.03M	210.71%2.93M
Net cash flow
Beginning cash position	-12.49%67.51M	-4.96%43.9M	86.31%89.36M	-17.04%47.96M	206.62%99.15M	85.46%77.15M	-53.66%46.19M	-17.04%47.96M	-34.11%57.81M	520.75%32.34M
Current changes in cash	-226.22%-27.77M	-23.73%23.61M	-2,466.63%-45.46M	520.16%41.39M	-162.64%-9.79M	337.52%22M	153.30%30.96M	-104.23%-1.77M	67.08%-9.85M	-70.29%15.63M
End cash Position	-59.91%39.74M	-12.49%67.51M	-4.96%43.9M	86.31%89.36M	86.31%89.36M	206.62%99.15M	85.46%77.15M	-53.66%46.19M	-17.04%47.96M	-17.04%47.96M
Free cash flow	37.81%-21.32M	-87.24%-30.27M	33.56%-25.78M	-29.12%-112.21M	-35.35%-22.97M	-14.83%-34.28M	38.88%-16.17M	-184.56%-38.8M	-22.84%-86.91M	19.39%-16.97M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data